Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently ...

The intervention being tested is Avacopan, an oral medication intended to provide long-term treatment for ANCA-associated vasculitis. The study includes three groups: one receiving Avacopan with ...

Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the first results from the open-label extension trial of the Phase 3 GATHER2 study, which demonstrated ...

Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a significantly higher overall risk of developing cancer, according to a systematic review and meta-analysis ...

Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...

Vasculitis is a group of diseases, also known as angiitis, that damage blood vessels by causing inflammation. It can affect any blood vessel anywhere in the body. Vasculitis means inflammation of the ...

The terrible pain started a week earlier, and she had already been to the emergency room twice. By Lisa Sanders, M.D. “You need to go back to the hospital,” the visiting nurse declared shortly after ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Mounting evidence from both clinical trials and observational studies show increased awareness on both treatment outcomes in ...